Veracyte Inc
VCYT
Market Cap$1.44B
Close$
$-5.12
125.8% downside
Current Fair Value
125.8% downsideOvervalued by 125.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.44 Billion |
|---|---|
| Enterprise Value | $1.24 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.02 |
| Beta | 2.03 |
| Outstanding Shares | 75,067,823 |
| Avg 30 Day Volume | 603,987 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -19.37 |
|---|---|
| PEG | -3.05 |
| Price to Sales | 4.96 |
| Price to Book Ratio | 1.53 |
| Enterprise Value to Revenue | 3.43 |
| Enterprise Value to EBIT | -70.93 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
ESG Score
No data
About Veracyte Inc
CEO: Bonnie Anderson